Trials / Completed
CompletedNCT04063644
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients
Effect of Visglyc on the Quality of Life of Patients With Dry Eye Symptomatology and Age-related Loss of Visual Acuity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- OPKO Health, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Clinical trial with medical devices, post-authorization, parallel, single-blind, randomized, comparative, prospective to study how afects the quality of life the use of ocular eye drops on patients with dry eye symptomatology and age-related loss of visual acuity. Secondary purposes: efects on the dry eye symptomatology, efect on visual acuity and treatment adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vis Glyc Neo | 1 drop in each eye, three times a day. |
| DEVICE | Physiological saline solution | 1 drop in each eye, three times a day. |
Timeline
- Start date
- 2019-05-30
- Primary completion
- 2020-12-22
- Completion
- 2020-12-22
- First posted
- 2019-08-21
- Last updated
- 2021-03-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04063644. Inclusion in this directory is not an endorsement.